Increased physiological dead space during exercise after bronchodilation in cystic fibrosis.
- 1 May 1993
- journal article
- Published by Wiley in Pediatric Pulmonology
- Vol. 15 (5) , 273-278
- https://doi.org/10.1002/ppul.1950150503
Abstract
Bicycle ergospirometry was performed on 14 patients with cystic fibrosis (CF), for evaluating the effects of salbutamol and theophylline on the ventilatory response to exercise. After 1 week without bronchodilator therapy the patients cycled at 1/3 and 2/3 of their individual maximal working capacity (Wmax). The test was repeated three times after treatment with salbutamol, theophylline, or both drugs, respectively. After the combined therapy, physiological deadspace, ventilation, ventilatory equivalent of oxygen, and end‐expiratory oxygen pressure increased significantly during steady state exercise at 1/3 Wmax. Similar, although not statistically significant changes, were observed after monotherapy with salbutarnol or theophylline and during exercise at 2/3 Wmax. These effects could not be predicted by any lung function tests at rest or by the Shwachman‐Kulczycki score. The results indicate that in some patients with CF bronchodilators can impair lung function during exercise. In conclusion the effects of medication on exercise performance of patients with CF have to be considered. Especially, the use of bronchodilators requires a careful evaluation of their real benefit in each individual patient.Keywords
This publication has 16 references indexed in Scilit:
- Variability of pulmonary function tests in cystic fibrosisPediatric Pulmonology, 1990
- Lung disease in cystic fibrosis—an updated conceptPediatric Pulmonology, 1990
- Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosisPediatric Pulmonology, 1990
- Maximum achievable bronchodilatation in asthmaRespiratory Medicine, 1989
- Airway obstruction and airway wall instability in cystic fibrosis: The isolated and combined effect of theophylline and sympathomimeticsPediatric Pulmonology, 1988
- Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.Thorax, 1980
- Bronchial hyperreactivity in cystic fibrosis and asthmaThe Journal of Pediatrics, 1978
- EARLY DETECTION OF PULMONARY FUNCTION ABNORMALITIES IN CYSTIC FIBROSISPediatrics, 1972
- PULMONARY MECHANICS IN ASTHMA AND CYSTIC FIBROSISPediatrics, 1971
- A comparison of the maximal endurance of normal children and patients with congenital cardiac diseaseThe Journal of Pediatrics, 1966